Alleviate Health Hiring 7 AI/Sales Roles as Clinical Trial Delays Cost $600K–$8M/Day

The Roles Alleviate Health Is Prioritizing Right Now

Alleviate Health, a 2023-founded startup automating patient recruitment for clinical trials with AI agents, posted seven specialized roles in mid-October 2026 — a signal flare from a nine-person team that has already proven its product at scale. Its conversational agents handle 500,000-plus patient interactions, Landed.jobs reported, across 190-plus research sites, Fast AI Jobs' data shows, addressing a problem where delays cost sponsors $600,000 to $8 million per day. The company raised a $4.3 million seed round in October 2025, Fast AI Jobs reported. Since then, the hiring signal has sharpened: Zero G Talent's board shows seven active openings, all based in San Francisco.

The split is deliberate. Three roles sit on the technical side: Founding AI Agent Engineer, Founding Product Engineer, and Business Operations. Four sit on the commercial side: Account Executive, Account Manager (listed at $140,000–$160,000, company ATS data shows), Business Development Representative, and Operations Associate, a title that maps to customer success in practice.

The salary bands tell their own story.

Every opening carries "AI Agents" or "outbound sales" as a primary keyword. That pairing isn't accidental. Alleviate's agents operate across SMS, voice, and email, engaging patients 24/7 to screen, schedule, and retain participants for clinical studies. The technical hires must extend agent reliability in a regulated, high-stakes workflow. The commercial hires must translate that reliability into contracts with research sites and sponsors who measure ROI in days saved per trial.

The Founding AI Agent Engineer and Founding Product Engineer roles signal that the core agent architecture is still being shaped, not just maintained. Business Operations and the Operations Associate suggest the company is building the post-sale machinery to keep sites live and expanding. The Account Executive and BDR pair maps to a classic land-and-expand motion: hunt new sites, then grow usage within each.

No remote listings appear. The team remains small enough that physical proximity still matters for the pace of iteration this hiring wave demands.

Why AI Agents and Sales Are the Dual Focus of This Hiring Wave

Clinical trial recruitment is the largest bottleneck in drug development and site revenue growth, per Alleviate Health's own description. The company's agent conducts outbound calls, qualifies patients against protocol criteria, and schedules screening visits — work that today falls to overburdened site coordinators. The first-party board data shows the company hiring a Founding AI Agent Engineer in San Francisco to build this system, while simultaneously staffing an Account Executive, a Business Development Representative, and an Account Manager to sell and support it. The Operations Associate role rounds out the post-sale motion. Every commercial hire maps to a deployment milestone: a health system or CRO that buys the platform needs implementation, training, and ongoing optimization, all of which require people who understand both the clinical workflow and the agent's behavior.

The broader market data explains why this dual focus is hardening across healthcare AI. Deloitte's 2026 survey found 61 percent of health care organizations are already building or budgeting for agentic AI initiatives, and 85 percent plan to increase investment over the next two to three years. Over 80 percent of health systems prioritize agentic AI for clinical operations and revenue cycle management; 70 percent of health plans target utilization management, prior authorization, and claims. But the same survey notes that early adopters are prioritizing multi-agent solutions (82 percent) while watchers prefer point solutions (92 percent) — a gap that widens the performance delta between organizations that can operationalize agents end-to-end and those that cannot. Alleviate Health's hiring pattern mirrors the early-adopter playbook: build the agent, then build the team that gets it embedded in customer workflows.

The economics reinforce the pairing. Assort Health, a peer in the referral-automation space, reported customers seeing a 5 percent lift in appointment volume, a 115 percent increase in labor capacity, up to $4.3 million per 100 providers in new revenue capture, 97 percent resolution rates, and a 79 percent referral-to-appointment conversion rate. Regal.ai cites 60 percent higher patient engagement, 46 percent higher conversion (14 percent in the first 14 days), and task completion jumping from 70 percent to 91 percent. Alleviate Health's own site claims a 12 percent reduction in hang-up rate and "thousands of hours" saved via human-in-the-loop workflows. Those numbers only convert to revenue if a sales team can articulate them to a VP of Clinical Operations or a CRO procurement lead, and if a success team can make them real after contract signature.

The talent market is pricing this hybridity. A JobLeads study found AI-related job postings grew 1,300 percent between 2024 and 2025, with healthcare leading all industries in salary growth for AI-literate professionals. AISE Pulse notes that every healthcare AI company reaching product-market fit needs sales engineers who can navigate clinical workflows, speak to regulatory requirements, and run demos where patient data privacy is non-negotiable. Alleviate Health's Business Operations role, typically spanning revenue ops, deal desk, and customer onboarding, sits exactly at that intersection. So does the Account Manager role, which at $140K–$160K base signals a quota-carrying, technical-commercial profile rather than pure relationship management.

The strategic logic is straightforward: the agent is the product, but the deployment is the business. In healthcare, deployment means integrating with EHRs, satisfying HIPAA and IRB requirements, training site coordinators who have never used an AI tool, and proving ROI in a budget cycle that demands evidence before renewal. You cannot hire engineers to solve the integration and compliance piece alone — they lack the customer context. You cannot hire salespeople to carry the technical credibility; they lack the product depth. Alleviate Health's seven-role wave is a bet that the only way to close the loop is to hire both sides at once, and to screen for people who can speak the other's language.

What Alleviate Health's Screen Actually Tests For

Alleviate Health's product philosophy reveals more about its hiring bar than any job description. The company builds conversational AI agents that pre-screen patients for clinical trials over SMS and voice, 500,000-plus interactions across 190-plus sites, optimized over 3 million conversations for conversion. But the platform doesn't run autonomously. Its core architecture is human-in-the-loop: recruiters jump in at the right moment, patients graduate to a human when the conversation demands it, and the team continually optimizes messaging, models, and workflows until study close-out. That design choice (AI handles scale, humans handle judgment) shapes what the company looks for in every hire, from the Founding AI Agent Engineer to the Account Executive.

The screen filters for candidates who have operated inside that tension. Alleviate's own marketing states it plainly: "The best recruiters are able to educate patients better, not just dial more." The same logic applies internally. A Business Development Representative who can't explain why a specific SMS sequence outperformed another by 21 percent on call-back rate won't last. An Account Manager who treats the AI as a black box instead of a tunable instrument, adjustable via the 150,000-conversation messaging library, creates friction with the clinical sites that trust Alleviate with their enrollment targets. The Operations Associate role, sitting between product and deployment, explicitly requires someone who can translate site feedback into workflow changes without breaking the compliance guardrails that govern patient data and do-not-contact preferences.

Technical roles face a parallel test. The Founding Product Engineer and Founding AI Agent Engineer aren't hired to chase benchmark leaderboards. They're hired to ship agents that integrate two-ways with CRIO, map screening answers to patient traits, auto-assign qualified patients to studies, and keep outreach lists current, all while respecting the regulatory and operational constraints of a clinical research site. That means the screen weighs experience with production LLM orchestration, eval-driven prompt engineering, and the unglamorous work of monitoring drift in live conversations higher than publication counts or model-architecture novelty.

The Business Operations role, often a catch-all at early-stage startups, here signals something specific: Alleviate needs someone who can connect the performance-based pricing model (tied directly to screening visits and randomizations) to the unit economics of each deployed agent. That's a commercial-technical hybrid skill set that doesn't appear on a standard resume. Candidates who have only sold SaaS seats or only optimized model latency tend to miss the through-line.

What the screen doesn't test for is equally telling. Alleviate's hiring materials don't emphasize pedigree, certifications, or framework-of-the-month fluency. The company's own product avoids the algorithmic hiring traps the EEOC has flagged: audio analysis that discriminates against speech impediments, personality proxies that screen out depression, "validated" tools that vendors claim absolve liability. Alleviate applies that same skepticism to its own talent evaluation. The screen is built to surface people who have shipped, iterated, and owned outcomes in messy, regulated, human-in-the-loop environments. The resume gets you the conversation. The evidence you bring to it gets you the role.

How This Reflects a Broader Shift in Healthcare AI Talent Demand

The FDA's running list of authorized AI-enabled medical devices crossed 1,600 entries as of September 2026. The same hospital systems that froze IT headcount in 2023 are now stacking two-tier AI organizations they did not have a name for eighteen months ago. KORE1's healthcare IT desk ran 41 active healthcare AI searches in the first four months of 2026 against 17 in the same window a year earlier, a 2.4x lift on a desk that does not chase trends. Healthcare tech hiring volume is up roughly 18 percent year-over-year, outpacing general tech's 8 percent growth, driven by interoperability mandates, AI governance requirements, and continued digitization of clinical workflows.

Most U.S. health systems are doubling their AI headcount this calendar year. Ambient scribes alone drove roughly one in three searches KORE1 ran this year, either at vendors such as Abridge, Suki, Nabla, and Nuance DAX or at the health systems rolling them out. The hiring followed the dollars.

But the demand is not confined to clinical documentation. Over 80 percent of health system and health plan executives agree that generative and agentic AI are poised to deliver moderate-to-significant value across clinical and business operations in 2026. Nearly all surveyed health plan executives (97 percent) and 83 percent of health system executives expect value in clinical functions specifically. Highmark Health deployed an AI agent with ambient listening to assemble clinical rationale and submit prior authorization requests in real time, collapsing processes that once took weeks into minutes. Sutter Health uses AI agents across chat, voice, and SMS channels, cutting interaction abandonment rates by 85 percent. New CMS regulations requiring standard prior authorization decisions in seven days instead of 14, effective January 1, 2026, have made agentic automation a compliance imperative as much as an efficiency play.

The talent market has not caught up. Clinical AI postings carry three distinguishing requirements absent from general AI roles: 78 percent require healthcare domain experience, 55 percent mention algorithmic fairness or bias testing, and 48 percent demand model explainability. Postings for FHIR/HL7 expertise are up 30 percent year-over-year; compliance engineering postings are up 65 percent. The intersection of engineering depth and healthcare domain knowledge is where the shortage is most acute. Strong engineers without clinical exposure need six to twelve months to develop domain fluency. Compliance professionals without engineering skills cannot design systems. Healthcare technology operates under constraints (HIPAA, FDA SaMD regulation, interoperability mandates, clinical workflow complexity) that general SaaS does not face.

That gap explains why Alleviate's screen prioritizes candidates who can bridge technical implementation and customer-facing delivery. The company's roles sit exactly at the seam where agentic AI meets real-world deployment. Deloitte's 2026 State of AI in the Enterprise survey found the AI skills gap is the biggest barrier to integration, and education (not role or workflow redesign) was the number-one way companies adjusted talent strategies. Worker access to AI rose 50 percent in 2025, and the number of companies with 40 percent or more projects in production is set to double in six months. Yet only one-third of healthcare organizations operate AI at scale; 49 percent are still experimenting, and 18 percent have not adopted at all.

The shift is structural. Seventy percent of healthcare executives plan alliances with technology or digital companies in 2026. Sixty-three percent expect strategic partnerships and joint ventures to become a higher priority. Vendors that can ship agents into clinical and administrative workflows, and support them with sales and success teams that understand the buyer's regulatory and operational reality, will capture the budgets now moving from pilot to line item. Alleviate's hiring surge is not an outlier. It is the leading edge of a market rewriting its org chart around applied AI implementers who can navigate both the code and the clinic.

The Hybrid Skill Set That's Becoming Non-Negotiable

The roles Alleviate Health is filling: Founding AI Agent Engineer, Founding Product Engineer, Account Executive, Business Development Representative, Account Manager sit on opposite sides of a divide that is collapsing. Five years ago, the engineer built the model and the salesperson sold it. Today, the engineer ships an AI agent that a clinic's front desk uses daily, and the salesperson needs to explain why that agent's confidence score matters for prior-authorization denials. The boundary has dissolved.

Research from across the sector confirms the shift. Vertical-specific domain expertise has become the primary differentiator for mid-to-senior AI sales engineers, and building that expertise takes 12 to 24 months of focused effort: reading industry publications, attending vertical conferences, studying regulatory frameworks, working deals in the vertical. A general-purpose AI SE can learn healthcare, but the ramp is long and the cost of credibility gaps is high.

What does the hybrid profile actually require? Start with technical fluency that stops short of research depth. Data literacy means reading a confidence score, understanding what a false positive means, and knowing when to override a model's suggestion. Prompt and tool fluency means querying clinical AI systems effectively. Regulatory and compliance awareness means HIPAA, GDPR, and FDA/SaMD classification basics — not abstractly, but well enough to answer a CIO's question on a discovery call. Cloud certifications with healthcare specializations (AWS HealthLake, Azure Health Data Services) show technical readiness. HL7 FHIR certifications signal interoperability expertise. HIPAA compliance certifications demonstrate baseline knowledge.

Pair that with customer engagement that goes beyond rapport. Human-centered communication means explaining an AI-assisted workflow to a frightened patient, or a skeptical practice manager, in plain, compassionate language. Ethical and bias awareness means recognizing when an algorithm under-performs for a specific demographic group and escalating appropriately. Critical thinking in complex situations, adaptability to new systems, decision-making under pressure — these now rank above repetitive administrative work and manual data processing on every skills forecast. The World Economic Forum's core-skills ranking places resilience, flexibility, and continuous learning just behind analytical thinking for 2030.

Gartner's data sharpens the point: process pros, not tech prodigies, unlock AI value. Teams redesigning workflows with AI are twice as likely to exceed revenue goals. Yet 70% of healthcare professionals say AI training is inadequate, inconsistent, or unavailable. The top training needs (checking the accuracy of AI recommendations, developing technical navigation skills, understanding legal liability) map directly to the hybrid gap. Companies that close it internally win; those that wait for the market to supply it lose.

Alleviate Health's board salary band of $140k–$160k median for salaried roles reflects a market that prices this blend at a premium. Those Founding AI Agent Engineer and Founding Product Engineer roles demand engineers who can sit with a customer and trace a failure mode to a prompt template. The Account Executive and Business Development Representative roles demand sellers who can diagram an EHR integration on a whiteboard. The hybrid is not a nice-to-have. It is the price of admission.

What This Means for Job Seekers Targeting Healthcare AI

The hiring surge at Alleviate Health — seven open roles spanning the founding AI agent engineer, the founding product engineer, Account Manager at $140K–160K, Account Executive, Business Development Representative, Business Operations, and Operations Associate — is a signal flare. The market is not looking for pure researchers. It is looking for builders who can ship inside a regulated clinical workflow and then sell the result to the people who run that workflow.

The numbers are stark. Christian & Timbers estimates roughly 2,000 engineers in the U.S. possess the blend of sector know-how, gravitas, and hands-on applied AI experience that enterprises actually need to see ROI. Demand for these forward-deployed engineers is projected to surge 2,100% by year-end. At the start of 2026 only 5–10% of companies planned to hire them; by the end of Q2 that figure hit 70%. There are about 17,000 people with the title on the market today, but a good chunk sit at Palantir, and "very few are capable of building your flagship AI product feature," as Christian put it. Most can roll out Claude Code. Few can make an agent that survives a HIPAA audit, an FDA CDS review, and a clinician's Friday afternoon chaos.

That gap is your entry point if you understand what the work actually is. MIT Sloan found that less than 20% of deployment effort goes to prompt engineering and model development. More than 80% is sociotechnical: data integration, model validation, governance, monitoring for drift, and designing around clinician workflows. For every hour you spend perfecting a model, expect four making it work in production. Candidates who show they have done that, who can point to a project where they wired an LLM into an EHR via FHIR R4, enforced deterministic guardrails with a Python validation layer, and forced structured JSON outputs matching HL7 standards, skip the line.

Compliance is not a checkbox. It is where most healthcare AI agent projects stall. You need to speak the language: BAA with your LLM provider, TLS 1.3 and AES-256 encryption, audit logging, RBAC, SOC 2 Type II readiness. You need to know the FDA has authorized over 1,600 AI-enabled medical devices as of September 2026 and that Section 3060(a) of the 21st Century Cures Act carves out certain decision-support software from the device definition. You need to understand that state-level AI regulations are layering on top of HIPAA and FDA guidance. If you can walk a hiring manager through how you would architect a Human-in-the-Loop system for a clinical touchpoint, where the agent drafts a prior-auth appeal but a nurse reviews before submit, you are already ahead of most applicants.

The resume test is practical. Healthcare organizations screen for candidates who minimize the "tech learning curve" and adapt fast to new workflows. That means bullet points with measurable outcomes: "Reduced documentation time 66 minutes per provider per day by integrating ambient scribing into Epic," or "Cut claim denial rate 67% for a 200-provider group by automating coding validation." Vague claims about "leveraging AI" get discarded. ATS filters look for technical depth, clinical rigor, security fluency, and quantified impact.

Certifications help but don't substitute for deployment scars. Allied health credentials signal domain fluency. But the hiring signal that matters is evidence you have navigated the full lifecycle: pilot design (prospective RCT, 200–500 patients per arm), success criteria defined upfront, vendor security vetting, and a monitoring plan with rollback thresholds. The maturity model runs Level 1 Exploration to Level 5 Transformation. Companies hiring now are building toward Level 3–4. They need people who have lived Level 2.

The tooling stack is settling. LangChain for RAG pipelines and EHR data chains. AutoGen for multi-agent reasoning loops. CrewAI for role-based agent teams. If you have built with these in a HIPAA-compliant environment, say so. If you haven't, spin up a side project that ingests synthetic FHIR data, runs a multi-agent prior-auth workflow, and outputs structured HL7, then document the failure modes you hit and how you fixed them. That portfolio piece is worth more than a certificate.

The market window is wide. Gartner forecasts 85% of healthcare organizations will deploy at least one AI agent in a clinical or administrative workflow by end of 2026. Seventy-three percent of health systems plan deployment within two years. The World Economic Forum projects a 10 million healthcare worker shortfall by 2030. Physicians burn 13.5–16 hours weekly on documentation. Fifteen percent of claims are denied on first submission, costing $20 billion annually to contest. The ROI surface is massive: Adonis delivered 4.5× ROI in year one for ApolloMD; Cohere Health processes 12 million authorizations annually near-real-time; MIRA outperformed board-certified physicians by 35 percentage points.

But the window favors specialists. The partner path (firms with pre-built HIPAA infrastructure, EHR integration patterns, and clinical workflow expertise) compresses 12+ months of in-house ramp. Alleviate Health and its peers are hiring to own that capability internally. They want engineers who can sit across from a CMIO, map the clinical workflow, architect the agent, and then help the sales team close the deal. That hybrid profile — technical fluency paired with customer-facing credibility — is the non-negotiable skill set for the next 24 months.

If you are early career, target forward-deployed or founding engineer roles at Series A–B healthcare AI companies. If you are mid-career, pivot from pure ML engineering or clinical informatics by shipping a production-grade agent in a regulated sandbox. If you are in sales, learn the compliance architecture cold; the best account executives in this space can diagram the data flow from EHR to agent to audit log. The hiring surge is real. The talent bar is high. The candidates who clear it are the ones who have already built something that survived contact with a hospital.

What's NOT Driving This Hiring Surge (and Why It Matters)

The seven open roles at Alleviate Health might look like a classic post-seed hiring sprint. They are not. That seed round, announced in October 2025 — a figure FundedIQ notes matches the median for healthcare companies across 29 tracked deals over the prior two years. That round closed months before most of these roles appeared on the board. The hiring wave is not a direct spend-down of fresh capital.

It is also not a headcount inflation play. Pitchbook lists nine total employees as of October 2026. FundedIQ places the company in the 1–10 employee band, according to Fast AI Jobs' data. Adding seven roles would nearly double the team. Companies padding org charts for investor optics don't typically target founding-level engineers and quota-carrying sales roles in the same cycle. They hire junior individual contributors who cost less and inflate numbers faster. Alleviate Health is doing the opposite: the board shows a founding AI agent engineer, a founding product engineer, an account executive, and a business development representative — all in San Francisco, all carrying meaningful ownership expectations.

Remote-work tailwinds are not the driver either. The BLS American Community Survey documents a dramatic remote-work increase across industries between 2019 and 2021. Alleviate Health was founded in early 2023, after that inflection. Every role on the board lists San Francisco as the location. The company is betting on in-person density for a product that sits at the intersection of clinical operations, regulatory nuance, and large-language-model deployment — a combination that resists async-only collaboration.

This is not an infrastructure or compute play. Public-market neoclouds such as CoreWeave have traded down roughly 20 percent, and the broader GPU-capacity debate dominates AI funding narratives. Alleviate Health sits at the application layer: its platform runs chatbots that screen patients against protocol criteria, schedule qualified leads for human recruiters, and feed a clinical-research-specific CRM. The company reports over 500,000 patient interactions, according to Fast AI Jobs, across 300-plus trials at 190-plus sites, Fast AI Jobs found, in the United States and Canada. Customers include Alcanza and CenExel, two of the largest clinical site networks. The product is live, revenue-generating, and embedded in workflows that sites rely on daily. The hiring surge follows proven traction, not speculative capacity bets.

Nor is this a pivot. The company launched publicly on October 13, 2025, announcing the same $4.3 million seed and the product's general availability. The roles now open map directly to the two engines that model requires: AI agents that handle 24/7 patient engagement via SMS and voice, and a go-to-market team that can sell into consolidated site networks and navigate procurement cycles at enterprise healthcare organizations. The Account Manager role carries a $140,000–$160,000 base salary band — the board's median — signaling that post-sale expansion and retention are already priorities, not afterthoughts.

Why the distinction matters: if you misread the signal as "AI hype raises money, money buys headcount," you will optimize for the wrong credentials. You will chase LLM research publications, generic prompt-engineering portfolios, or SaaS sales playbooks built for horizontal tools. Alleviate Health's screen — and the screens at peer companies like Flok Health, Voio, and Confido Health — filters for something narrower: engineers who have shipped LLM-backed features into regulated, high-stakes workflows, and commercial operators who can translate clinical-site pain into a procurement-ready business case. The hiring surge is not a symptom of capital availability. It is a symptom of product-market fit in a $50 billion clinical-trial market where recruitment delays consume 80 percent of timelines and 30 percent of costs. The roles exist because the bottleneck has moved from "can the model work?" to "can we deploy it across 190 sites, integrate with their EHRs, and train their staff before the next protocol amendment lands?" That is a different problem, and it demands a different hire.

Working in frontier tech? Zero G Talent tracks the openings: see every open Alleviate Health role, browse frontier tech jobs, the companies hiring, and the people building the field.